Evidence map›Paper›PMID 38563751›Full record

Trial reportAntimicrobial agents and chemotherapy2024

A randomized assessors-blind clinical trial to evaluate the safety and the efficacy of albendazole alone and in combination with mebendazole or pyrantel for the treatment of

Paul Alvyn Nguema Moure, Moustapha Nzamba Maloum, Gédéon Prince Manouana, Roméo-Aimé Laclong Lontchi, Mirabeau Mbong Ngwese, Jean Ronald Edoa, Jeannot Fréjus Zinsou, Brice Meulah, Saidou Mahmoudou, Elsy Mirna N'noh Dansou and 9 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 4 countries.

Paul Alvyn Nguema MoureCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Moustapha Nzamba MaloumCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Gédéon Prince ManouanaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Roméo-Aimé Laclong LontchiCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Mirabeau Mbong NgweseCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Jean Ronald EdoaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Jeannot Fréjus ZinsouCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Brice MeulahCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Saidou MahmoudouCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Elsy Mirna N'noh DansouCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Yabo Josiane HonkpehedjiCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Bayode Romeo AdegbiteCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Selidji Todagbe AgnandjiCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Michael RamharterCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Bertrand LellCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Steffen BorrmannCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Peter G KremsnerCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Jean Claude Dejon-AgobéCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0003-3816-998X
Ayôla Akim AdegnikaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.ORCID 0000-0003-3197-5946
Centre de Recherche Médicales de Lambaréné · GAUniversitätsklinikum Tübingen · DELeiden University Medical Center · NLUniversität Hamburg · DE

Funding

Bundesministerium für Wirtschaftliche Zusammenarbeit und Entwicklung (BMZ)Deutsches Zentrum für Infektionsforschung (DZIF)KfW Entwicklungsbank (KfW Development Bank)
6 · The paper itself

Abstract

Helminthiasis remains a public health issue in endemic areas. Various drugs have been proposed to improve efficacy against helminths. The study aimed to assess the safety and efficacy of three different anthelmintic combinations to treat

Indexed as

AlbendazoleAnthelminticsMebendazolePyrantelTrichuriasisTrichurisAdolescentAnimalsChildChild, PreschoolDrug Therapy, CombinationFemaleHumansMaleParasite Egg CountTreatment OutcomeAlbendazoleAnthelminticsMebendazolePyrantelalbendazolebenzimidazole combinationcoinfectionefficacymebendazolepyrantelsafetytrichuriasisTrichuris trichiura

Identifiers

PMID38563751
PMCPMC11064543
OpenAlexW4393411839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.